Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-12-2023 | Ramucirumab | Case report

Capecitabine/Pembrolizumab/Ramucirumab

Delayed oesophageal anastomotic leak and lack of efficacy

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Roth RH, et al. Delayed esophageal anastomotic complication and ramucirumab therapy: A case report. Thoracic Cancer 14 : 2976-2980, Oct 2023. Available from: URL: https://dx.doi.org/10.1111/1759-7714.15084 Roth RH, et al. Delayed esophageal anastomotic complication and ramucirumab therapy: A case report. Thoracic Cancer 14 : 2976-2980, Oct 2023. Available from: URL: https://dx.doi.org/10.1111/1759-7714.15084
Metadata
Title
Capecitabine/Pembrolizumab/Ramucirumab
Delayed oesophageal anastomotic leak and lack of efficacy
Publication date
01-12-2023
Publisher
Springer International Publishing
Keyword
Ramucirumab
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50906-0

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Prednisolone

Case report

Nivolumab

Case report

Adalimumab

Case report

Warfarin